Chelation Therapy for Off-Label Uses

Off-label applications of chelation therapy (see Policy Guidelines section for uses approved by the U.S. Food and Drug Administration) are considered investigational, including, but not limited to:

Alzheimer disease

atherosclerosis (eg, coronary artery disease, secondary prevention in individulas with myocardial infarction, or peripheral vascular disease)

autism

diabetes

multiple sclerosis

arthritis (includes rheumatoid arthritis).